Pulse Biosciences, Inc. (PLSE)
52.94
+4.14
(+8.50%)
USD |
NASDAQ |
Sep 09, 16:00
53.50
+0.56
(+1.07%)
After-Hours: 18:10
Pulse Biosciences Profit Margin (Quarterly) : -5.68K% for June 30, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -5.68K% |
| March 31, 2026 | -4.63K% |
| December 31, 2025 | -6.60K% |
| September 30, 2025 | -22.54K% |
| June 30, 2025 | |
| March 31, 2025 | |
| December 31, 2024 | |
| September 30, 2024 | |
| June 30, 2024 | |
| March 31, 2024 |
| Date | Value |
|---|---|
| December 31, 2023 | |
| September 30, 2023 | |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | -5.28K% |
| March 31, 2022 | -3.89K% |
| December 31, 2021 | -1.83K% |
| September 30, 2021 | -2.49K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Accuray, Inc. | -1.92% |
| Micron Solutions, Inc. | -- |
| Orthofix Medical, Inc. | -7.49% |
| ResMed, Inc. | 26.20% |
| Rockwell Medical, Inc. | -6.59% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -90.23% |
| Return on Assets | -76.64% |
| Return on Invested Capital | -83.18% |
| Gross Profit Margin (Quarterly) | 37.10% |
| Operating Margin (Quarterly) | -5.82K% |
| Return on Net Operating Assets | -747.1% |